MAP Pharmaceuticals Stock Price, News & Analysis (NASDAQ:MAPP)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About MAP Pharmaceuticals (NASDAQ:MAPP)

MAP Pharmaceuticals logoMAP Pharmaceuticals, Inc., incorporated on July 3, 2003, is a development-stage company. As of December 31, 2011, the Company was focusing to advance its product candidate, LEVADEX (MAP0004) orally inhaled migraine therapy, which is an orally inhaled version of dihydroergotamine mesylate (DHE), for the acute treatment of migraine. The Company had completed clinical development for LEVADEX in 2011 and submitted its New Drug Application (NDA) to the United States Food and Drug Administration (FDA). LEVADEX is at-home therapy in development that patients self-administer using its hand-held TEMPO inhaler. Effective March 1, 2013, Allergen Inc acquired the entire share capital of MAP Pharmaceuticals Inc.

Receive MAPP News and Ratings via Email

Sign-up to receive the latest news and ratings for MAPP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:MAPP
CUSIPN/A
WebN/A
Phone+1-302-6587581

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

MAP Pharmaceuticals (NASDAQ:MAPP) Frequently Asked Questions

What is MAP Pharmaceuticals' stock symbol?

MAP Pharmaceuticals trades on the NASDAQ under the ticker symbol "MAPP."

Who are some of MAP Pharmaceuticals' key competitors?

How do I buy MAP Pharmaceuticals stock?

Shares of MAP Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact MAP Pharmaceuticals?

MAP Pharmaceuticals' mailing address is 2525 Dupont Dr, IRVINE, CA 92612-1531, United States. The healthcare company can be reached via phone at +1-302-6587581.


MarketBeat Community Rating for MAP Pharmaceuticals (MAPP)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  122
MarketBeat's community ratings are surveys of what our community members think about MAP Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MAP Pharmaceuticals (NASDAQ:MAPP) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

MAP Pharmaceuticals (NASDAQ:MAPP) Earnings History and Estimates Chart

Earnings by Quarter for MAP Pharmaceuticals (NASDAQ:MAPP)

MAP Pharmaceuticals (NASDAQ MAPP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2012Q3 2012($0.39)($0.38)ViewN/AView Earnings Details
7/24/2012Q2 2012($0.43)($0.43)ViewN/AView Earnings Details
5/4/2012Q1 2012($0.40)($0.49)ViewN/AView Earnings Details
3/29/2012Q4 2011($0.30)($0.45)ViewN/AView Earnings Details
11/8/2011Q3 2011$0.35$0.36ViewN/AView Earnings Details
8/4/2011Q2 2011($0.38)($0.28)ViewN/AView Earnings Details
5/3/2011Q1 2011($0.39)$0.56ViewN/AView Earnings Details
3/1/2011Q4 2010($0.44)($0.46)ViewN/AView Earnings Details
11/5/2010Q3 2010($0.45)($0.53)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.48)($0.47)ViewN/AView Earnings Details
5/4/2010Q1 2010($0.52)($0.54)ViewN/AView Earnings Details
3/2/2010Q4 2009($0.41)($0.54)ViewN/AView Earnings Details
11/5/2009Q3 2009$0.94$0.80ViewN/AView Earnings Details
8/3/2009Q2 2009($0.43)($0.24)ViewN/AView Earnings Details
5/7/2009Q1 2009($0.80)($0.48)ViewN/AView Earnings Details
3/2/2009Q4 2008($0.97)($1.07)ViewN/AView Earnings Details
11/12/2008Q3 2008($0.88)($1.00)ViewN/AView Earnings Details
8/12/2008Q2 2008($0.82)($0.81)ViewN/AView Earnings Details
5/12/2008Q1 2008($0.76)($0.71)ViewN/AView Earnings Details
2/28/2008Q4 2007($0.45)($0.76)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

MAP Pharmaceuticals (NASDAQ:MAPP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for MAP Pharmaceuticals (NASDAQ:MAPP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MAP Pharmaceuticals (NASDAQ MAPP)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

MAP Pharmaceuticals (NASDAQ MAPP) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

MAP Pharmaceuticals (NASDAQ:MAPP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

MAP Pharmaceuticals (NASDAQ:MAPP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

MAP Pharmaceuticals (NASDAQ MAPP) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.